Skip to content

Multicenter clinical study of RDN in patients with left ventricular ejection fraction non-retention type heart failure

Multicenter clinical study of RDN in patients with left ventricular ejection fraction non-retention type heart failure

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030612
Enrollment
Unknown
Registered
2020-03-08
Start date
2020-03-16
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure

Interventions

group of RDN:RDN
group of medication:Heart failure medication

Sponsors

Shanghai Putuo District Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Included patients diagnosed with chronic heart failure in our hospital and in four hospitals outside from September 2019 to August 2022. Han nationality, aged 18-80 years. The heart function of NYHA was more than grade 2, and the heart ultrasound examination EF was less than 50%. 2. Signature of the informed consent with the full informed consent of the above criteria.

Exclusion criteria

Exclusion criteria: 1. The patients had a history of renal artery stenosis or imaging showed a history of renal artery stenosis. 2. Patients with GFR <30 ml/min/1.73; 3. Type 1 diabetes; 4. Severe heart valve disease; 5. Pregnancy or planning during the course of the study; 6. Acute stage of myocardial infarction and cerebrovascular accident; 7. CRT pacemaker implanted.

Design outcomes

Primary

MeasureTime frame
LVEF;Cardiopulmonary exercise test;BNP;Incidence of malignant arrhythmia;

Countries

China

Contacts

Public ContactYang Wei

Shanghai Putuo District Central Hospital

michaelyang1025@163.com+86 13817057122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026